{
    "title": "Adderall Risks: Much More Than You Wanted To Know",
    "date": "December 28, 2017",
    "links": [
        "https://slatestarcodex.com/2017/03/06/antidepressant-pharmacogenomics-much-more-than-you-wanted-to-know/",
        "https://slatestarcodex.com/2014/07/07/ssris-much-more-than-you-wanted-to-know/",
        "https://slatestarcodex.com/tag/much-more-than-you-wanted-to-know/",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268520/",
        "https://www.ncbi.nlm.nih.gov/pubmed/21923806",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154646/",
        "https://www.ncbi.nlm.nih.gov/books/NBK53648/",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489818/",
        "http://exiledonline.com/adderall-tips-how-to-convince-your-shrink-you-have-addadhd/all/1/",
        "https://thoughtcatalog.com/sarah-miller/2015/03/how-to-get-your-doctor-to-prescribe-you-adderall-in-5-easy-steps/",
        "https://slatestarcodex.com/2013/11/10/highlights-from-my-notes-from-a-forensic-psychiatry-conference-last-week/",
        "https://theunitofcaring.tumblr.com/post/168201153351/have-you-looked-into-adhd-your-posts-from",
        "https://luxury.rehabs.com/adderall-addiction/statistics/",
        "https://link.springer.com/article/10.1007/s00787-010-0140-6",
        "http://www.cvriskcalculator.com/",
        "https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/1471-2261-12-41",
        "http://journals.lww.com/psychopharmacology/Abstract/2009/10000/Atomoxetine_and_Cerebrovascular_Outcomes_in_Adults.8.aspx",
        "https://jamanetwork.com/journals/jama/fullarticle/1104778",
        "https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2011.11010125",
        "https://bmcpsychiatry.biomedcentral.com/articles/10.1186/1471-244X-12-221",
        "http://sci-hub.tw/10.1542/peds.2008-0185",
        "https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/ritalin_ritalin-sr.pdf",
        "https://www.researchgate.net/publication/21601219_Relapse_of_Paranoid_Psychotic_State_in_Methamphetamine_Model_of_Schizophrenia",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1524735/",
        "https://www.ncbi.nlm.nih.gov/pubmed/11125642",
        "https://www.ncbi.nlm.nih.gov/pubmed/14437533",
        "http://www.sciencedirect.com.sci-hub.tw/science/article/pii/S0890856709620608",
        "http://pediatrics.aappublications.org/content/134/1/e293",
        "http://www.sciencedirect.com.sci-hub.tw/science/article/pii/S1389945707000809",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063150/",
        "http://mentalhealthdaily.com/2015/12/28/adderall-tolerance-causes-how-to-prevent-it/",
        "https://www.nature.com/articles/mp200890",
        "http://static1.1.sqspcdn.com/static/f/1072889/14646694/1318709133433/Parkinson%27s+Risk+in+meth_amphetamine+users+2011.pdf?token=GYphr5yCttsle9gFybCiUoO0wBo%3D",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295903/",
        "https://www.sciencedaily.com/releases/2011/02/110220193013.htm",
        "http://www.sciencedirect.com/science/article/pii/S0161813X06000921",
        "https://www.ncbi.nlm.nih.gov/pubmed/17982908",
        "https://scienceofparkinsons.com/2017/03/23/adhd-and-parkinsons-disease/",
        "https://www.sciencedaily.com/releases/2011/01/110118092132.htm",
        "https://www.ncbi.nlm.nih.gov/pubmed/28176268",
        "http://www.brainprotips.com/adderall-neurotoxicity/",
        "https://slatestarcodex.com/2015/10/28/meat-your-doom/"
    ],
    "url": "https://slatestarcodex.com/2017/12/28/adderall-risks-much-more-than-you-wanted-to-know/",
    "summary": "Key ideas:\n- Psychiatrists spend a lot of time gatekeeping Adderall\n- Attention is a normally distributed trait and ADHD diagnosis is difficult\n- Adderall works for people whether they have ADHD or not to increase focus and attention\n- Psychiatrists are limited in their ability to discern truth from deception in patients\n- There are many risks associated with Adderall, however, most are minor and do not outweigh the benefits\n- Medical risks of stimulant use are generally low and outweighed by benefits for most people.\n- Serious cardiac abnormalities are rare and similar to rates seen in the general pediatric population.\n- Psychosis and aggressive behavior can occur with high doses or misuse of stimulants, but are rare on prescribed doses and typically resolve quickly.\n- The risk of sudden death is low and comparable to the general population.\n- Addiction risk is difficult to define and measure, but is generally believed to be low when stimulants are taken as prescribed by responsible individuals.\n- Despite no sign of withdrawal effects, benefits of Adderall and other stimulants tend to stop working after several years of treatment.\n- The MTA study, which found this result, has been critiqued for not being controlled correctly.\n- Amphetamines seem to cause permanent cellular damage in rodents and non-human primates, particularly by decreasing striatal dopamine.\n- Although Adderall use doesn't cause heart attacks or strokes, it may increase the risk of addiction, psychosis, and Parkinson's disease in the long term.\n\nKey learnings:\n- Only people who \"genuinely\" \"have\" \"ADHD\" should be prescribed Adderall, but the definitions and criteria for ADHD are unclear\n- Adderall is used to aid focus and attention, not to enhance cognition\n- The risks associated with Adderall use are minor and unlikely to outweigh the potential benefits for most people\n- The medical risks of stimulant use are generally low and should not deter responsible individuals from taking them as prescribed.\n- Misuse and abuse of stimulants increase the risk of cardiac abnormalities, psychosis, aggressive behavior, and addiction.\n- The benefits of treating ADHD with stimulants outweigh the risks for most people.\n- Any benefits of stimulants will not last forever and might stop working after several years of treatment.\n- The reported rates of mental side effects associated with stimulant use are particularly low.\n- Amphetamines, particularly Adderall, have not been seen to cause heart attacks or strokes.\n\nKey questions:\n- How can psychiatrists effectively discern truth from deception in patients seeking Adderall?\n- What could be a more principled definition of ADHD?\n- How can we balance the need to limit access to Adderall with the need to help those who genuinely need it?\n- What is the incidence of serious cardiac abnormalities in the general population?\n- What is the incidence of long-term psychosis in individuals who take stimulants?\n- How does addiction risk vary depending on demographic factors such as age, gender, and family history?\n- Are there any effective alternatives to stimulant therapy for treating ADHD?\n- Does the possibility of amphetamines increasing the risk of Parkinson's disease make them riskier than previously thought?\n- How can we ensure that those who should still take medication are still informed about the potential risks?\n- What ethical implications are at play when prescribing Adderall and other commonly-used ADHD medications, particularly in terms of appropriate care?\n"
}